サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：大腸菌検査の世界市場
市場調査レポート
商品コード
1199077

大腸菌検査の世界市場

E. Coli Testing
出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 159 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.42円
大腸菌検査の世界市場
出版日: 2023年01月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 159 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界の大腸菌検査の市場規模は、2022年の21億米ドルから2030年までに32億米ドルに達し、2022年～2030年にCAGRで5.3%の成長が予測されています。

当レポートでは、世界の大腸菌検査市場について調査分析し、市場の動向と促進要因、地域分析、競合情勢などを提供しています。

調査対象企業の例（全14社）：

  • Accugen Laboratories, Inc.
  • Alere, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • DiaSorin SpA
  • Eiken Chemical Co., Ltd.
  • Enzo Life Sciences, Inc.
  • InstantLabs
  • Luminex Corporation
  • Meridian Bioscience, Inc.
  • Mobidiag
  • Pro-Lab Diagnostics, Inc.
  • QIAGEN GmbH
  • Romer Labs, Inc.
  • Vivione Biosciences, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場の概要
  • 主要企業
  • 市場の動向と促進要因
  • 世界市場の見通し

第3章 市場の分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他の欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他のアジア太平洋
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他のラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他の中東
  • アフリカ

第4章 競合

目次
Product Code: MCP11661

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global E. Coli Testing Market to Reach $3.2 Billion by 2030

In the changed post COVID-19 business landscape, the global market for E. Coli Testing estimated at US$2.1 Billion in the year 2022, is projected to reach a revised size of US$3.2 Billion by 2030, growing at aCAGR of 5.3% over the period 2022-2030. Environmental Testing, one of the segments analyzed in the report, is projected to record 5.8% CAGR and reach US$2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Clinical Testing segment is readjusted to a revised 4.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $581.6 Million, While China is Forecast to Grow at 8.8% CAGR

The E. Coli Testing market in the U.S. is estimated at US$581.6 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$703.7 Million by the year 2030 trailing a CAGR of 8.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.8% and 5.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Select Competitors (Total 14 Featured):

  • Accugen Laboratories, Inc.
  • Alere, Inc.
  • Becton, Dickinson and Company
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • DiaSorin SpA
  • Eiken Chemical Co., Ltd.
  • Enzo Life Sciences, Inc.
  • InstantLabs
  • Luminex Corporation
  • Meridian Bioscience, Inc.
  • Mobidiag
  • Pro-Lab Diagnostics, Inc.
  • QIAGEN GmbH
  • Romer Labs, Inc.
  • Vivione Biosciences, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • E-Coli: An Overview
    • E.Coli Testing Market to Grow at a Burgeoning Rate
    • E. Coli Testing - Global Key Competitors Percentage Market Share in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Morbidity and Mortality Rates Associated with E Coli to Spur the Demand for E.Coli Testing
    • Increasing Popularity of PCR Testing to Propel the Market for E.Coli Testing
    • Testing of Bottled Water for E.Coli
    • Anti-biotic Resistance of E.Coli Testing by PCR Tests
    • New Technological Advancements Offer Significant Opportunities for Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for E. Coli Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for E. Coli Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for E. Coli Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Environmental Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Environmental Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Environmental Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Clinical Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Clinical Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Clinical Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 10: World E. Coli Testing Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 11: USA Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 12: USA Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 13: USA 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 15: Canada Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 16: Canada 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2023 & 2030
  • JAPAN
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 17: Japan Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 18: Japan Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 19: Japan 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2023 & 2030
  • CHINA
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 21: China Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 22: China 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2023 & 2030
  • EUROPE
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 23: Europe Recent Past, Current & Future Analysis for E. Coli Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 24: Europe Historic Review for E. Coli Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 25: Europe 16-Year Perspective for E. Coli Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 26: Europe Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2023 & 2030
  • FRANCE
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 29: France Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 30: France Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 31: France 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2023 & 2030
  • GERMANY
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 32: Germany Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Germany Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 34: Germany 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 35: Italy Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 36: Italy Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 37: Italy 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 38: UK Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: UK Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 40: UK 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2023 & 2030
  • SPAIN
    • TABLE 41: Spain Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 42: Spain Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 43: Spain 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2023 & 2030
  • RUSSIA
    • TABLE 44: Russia Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Russia Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 46: Russia 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 49: Rest of Europe 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for E. Coli Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for E. Coli Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 52: Asia-Pacific 16-Year Perspective for E. Coli Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2023 & 2030
  • AUSTRALIA
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
    • TABLE 56: Australia Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Australia Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 58: Australia 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2023 & 2030
  • INDIA
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
    • TABLE 59: India Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 60: India Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 61: India 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2023 & 2030
  • SOUTH KOREA
    • TABLE 62: South Korea Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: South Korea Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 64: South Korea 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2023 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Rest of Asia-Pacific Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 67: Rest of Asia-Pacific 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2023 & 2030
  • LATIN AMERICA
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 68: Latin America Recent Past, Current & Future Analysis for E. Coli Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 69: Latin America Historic Review for E. Coli Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 70: Latin America 16-Year Perspective for E. Coli Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2023 & 2030
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2023 & 2030
  • ARGENTINA
    • TABLE 74: Argentina Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Argentina Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 76: Argentina 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2023 & 2030
  • BRAZIL
    • TABLE 77: Brazil Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 78: Brazil Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 79: Brazil 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2023 & 2030
  • MEXICO
    • TABLE 80: Mexico Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Mexico Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 82: Mexico 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2023 & 2030
  • REST OF LATIN AMERICA
    • TABLE 83: Rest of Latin America Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Rest of Latin America Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 85: Rest of Latin America 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2023 & 2030
  • MIDDLE EAST
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
    • TABLE 86: Middle East Recent Past, Current & Future Analysis for E. Coli Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 87: Middle East Historic Review for E. Coli Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 88: Middle East 16-Year Perspective for E. Coli Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2023 & 2030
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2023 & 2030
  • IRAN
    • TABLE 92: Iran Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Iran Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 94: Iran 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2023 & 2030
  • ISRAEL
    • TABLE 95: Israel Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Israel Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 97: Israel 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2023 & 2030
  • SAUDI ARABIA
    • TABLE 98: Saudi Arabia Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Saudi Arabia Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 100: Saudi Arabia 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2023 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 101: UAE Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 102: UAE Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 103: UAE 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2023 & 2030
  • REST OF MIDDLE EAST
    • TABLE 104: Rest of Middle East Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Rest of Middle East Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 106: Rest of Middle East 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2023 & 2030
  • AFRICA
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
    • TABLE 107: Africa Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Africa Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 109: Africa 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2023 & 2030

IV. COMPETITION